Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail P Jarvik

Showing results (21-30 of 412) with videos related to

Pageof 42
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Response to Phillips et alCaroline S Bennette, Wylie Burke, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2013
Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genesBrian H Shirts, Angela Jacobson, Gail P Jarvik, et al.
Pharmacogenomics|September 13, 2013
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in diseaseDaniel Seung Kim, Judit Marsillach, Clement E Furlong, et al.
European Journal of Human Genetics : EJHG|May 27, 2018
Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experimentDeirdre Weymann, David L Veenstra, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 26, 2014
Regulatory changes raise troubling questions for genomic testingBarbara J Evans, Michael O Dorschner, Wylie Burke, et al.
Chemico-Biological Interactions|May 31, 2016
Paraoxonases-1, -2 and -3: What are their functions?Clement E Furlong, Judit Marsillach, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2011
Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisionsMitzi L Murray, Felecia Cerrato, Robin L Bennett, et al.
Annual Review of Medicine|January 15, 2003
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolismLucio G Costa, Toby B Cole, Gail P Jarvik, et al.
Pharmacogenomics|June 8, 2002
Pharmacogenomic considerations of the paraoxonase polymorphismsClement E Furlong, Toby B Cole, Gail P Jarvik, et al.
Health Policy and Technology|May 27, 2021
Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testingCameron B Haas, Aaron Scrol, Chethan Jujjavarapu, et al.
Pageof 42

Showing results (21-30 of 412) with videos related to

Sort By:
Pageof 42
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Response to Phillips et alCaroline S Bennette, Wylie Burke, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2013
Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genesBrian H Shirts, Angela Jacobson, Gail P Jarvik, et al.
Pharmacogenomics|September 13, 2013
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in diseaseDaniel Seung Kim, Judit Marsillach, Clement E Furlong, et al.
European Journal of Human Genetics : EJHG|May 27, 2018
Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experimentDeirdre Weymann, David L Veenstra, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 26, 2014
Regulatory changes raise troubling questions for genomic testingBarbara J Evans, Michael O Dorschner, Wylie Burke, et al.
Chemico-Biological Interactions|May 31, 2016
Paraoxonases-1, -2 and -3: What are their functions?Clement E Furlong, Judit Marsillach, Gail P Jarvik, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2011
Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisionsMitzi L Murray, Felecia Cerrato, Robin L Bennett, et al.
Annual Review of Medicine|January 15, 2003
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolismLucio G Costa, Toby B Cole, Gail P Jarvik, et al.
Pharmacogenomics|June 8, 2002
Pharmacogenomic considerations of the paraoxonase polymorphismsClement E Furlong, Toby B Cole, Gail P Jarvik, et al.
Health Policy and Technology|May 27, 2021
Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testingCameron B Haas, Aaron Scrol, Chethan Jujjavarapu, et al.
Pageof 42